Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
Clinical trial NCT00699192 · COMPLETED
Trial details
- NCT number
- NCT00699192
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-05-01
- Enrollment
- 965
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.